ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 35 (10) , 1390-1394
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorBlood, 2010
- Tolerance checkpoints in B‐cell development: Johnny B goodEuropean Journal of Immunology, 2009
- RNAi screen for rapid therapeutic target identification in leukemia patientsProceedings of the National Academy of Sciences, 2009
- Contrasting Responses of Lymphoid Progenitors to Canonical and Noncanonical Wnt SignalsThe Journal of Immunology, 2008
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapyInternational Journal of Cancer, 2008
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5aProceedings of the National Academy of Sciences, 2008
- Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic LeukemiaClinical Cancer Research, 2008
- Expansion of B cell precursors after unrelated cord blood transplantation for an adult patientBone Marrow Transplantation, 2007
- Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALLLeukemia, 1999
- Hematogones in the Bone Marrow of Adults:Immunophenotypic Features, Clinical Settings, and Differential DiagnosisAmerican Journal of Clinical Pathology, 1994